Clinical Trial Update: Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Olatorepatide in adults with overweight or obesity in the United States. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Olatorepatide (olatorepatide)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Overweight or Obesity | Phase 2 | Status: RECRUITING